Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lymphoma 2011 NIDCR 5F31DE019599-03 Early events in infection of epithelial cells with Epstein-Barr Virus VALENCIA, SARAH LOUISIANA STATE UNIV HSC SHREVEPORT LA $27,059
Lymphoma 2011 NCI 5R01CA131354-03 Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $358,438
Lymphoma 2011 NCI 5R01CA096856-08 Novel role of STAT3 in NPM/ALK-induced oncogenesis WASIK, MARIUSZ UNIVERSITY OF PENNSYLVANIA PA $290,381
Lymphoma 2011 NCI 5R01CA077429-12 Basis for Lymphomagenesis in Akt2 Transgenic Mice TESTA, JOSEPH FOX CHASE CANCER CENTER PA $419,987
Lymphoma 2011 NCI 5R01CA129330-03 Origin of CD5+ B cell Lymphoma/Leukemia in Mice HAYAKAWA, KYOKO INSTITUTE FOR CANCER RESEARCH PA $351,225
Lymphoma 2011 NCI 5R01CA100603-09 Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer CLEVELAND, JOHN SCRIPPS RESEARCH INSTITUTE CA $417,344
Lymphoma 2011 NCI 4R37CA031845-31 Synthetic Studies Related to Cancer Research/Treatment WENDER, PAUL STANFORD UNIVERSITY CA $423,345
Lymphoma 2011 NCI 5R01CA052004-22 Control of Gammaherpesvirus Replication SPECK, SAMUEL EMORY UNIVERSITY GA $310,549
Lymphoma 2011 NCI 5R01CA138891-02 In vivo targeting of hematopoetic cells with glycan ligands of siglecs PAULSON, JAMES SCRIPPS RESEARCH INSTITUTE CA $384,203
Lymphoma 2011 NCI 5R01CA124621-06 Role of Arsenic Trioxide in Primary Effusion Lymphoma CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $298,566
Lymphoma 2011 NCI 5R21CA141275-02 Characterizing Clonogenic Populations in Mantle Cell Lymphoma MCCARTY, NAMI UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $189,878
Lymphoma 2011 NCI 5R01CA139389-02 Lymphoma Therapy with Reprogrammed Measles Viruses CATTANEO, ROBERTO MAYO CLINIC MN $304,127
Lymphoma 2011 NIAID 5R01AI065529-05 Regulatory Networks of Helicobacter pylori MERRELL, D HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $367,285
Lymphoma 2011 NIAID 5R01AI079732-09 Accessibility Control of Antigen Receptor Gene Assembly OLTZ, EUGENE WASHINGTON UNIVERSITY MO $372,438
Lymphoma 2011 NCI 5R01CA116093-05 Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis SIF, SAID OHIO STATE UNIVERSITY OH $248,805
Lymphoma 2011 NCI 5R01CA080320-12 Myc Oncogene Mutations and Polymorphisms in Cancer COLE, MICHAEL DARTMOUTH COLLEGE NH $336,775
Lymphoma 2011 NCI 5R01CA140806-02 Proteomic biomarkers of ALK+ lymphoma LIM, MEGAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $310,970
Lymphoma 2011 NCI 5R37CA042245-26 Regulation of replication and latency EBV EBNAs HAYWARD, S JOHNS HOPKINS UNIVERSITY MD $356,292
Lymphoma 2011 NCI 5R01CA136895-03 Molecular targets in diffuse large B cell lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $251,191
Lymphoma 2011 NCI 4R37CA076584-14 F-box proteins: deregulated cell cycle control and proteolysis in cancer PAGANO, MICHELE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $446,545
Lymphoma 2011 NCI 5R01CA031534-27 MAR Mediated Control of The IgH Enhancer TUCKER, PHILIP UNIVERSITY OF TEXAS AUSTIN TX $249,638
Lymphoma 2011 NCI 5R01CA137894-03 EBV Antigen and Cell Cycle Regulation ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $285,308
Lymphoma 2011 NCI 5R01CA102705-08 Mismatch repair in V region mutation and isotype switching SCHARFF, MATTHEW ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $314,906
Lymphoma 2011 NCI 5R01CA033192-24 Transformation by Reticuloendotheliosis Virus BOSE, HENRY UNIVERSITY OF TEXAS AUSTIN TX $292,972
Lymphoma 2011 NCI 5R01CA078384-13 E2A as a Tumor Suppressor MURRE, CORNELIS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $398,017
Lymphoma 2011 NCI 5R21CA143785-02 Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma. NEELAPU, SATTVA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $279,772
Lymphoma 2011 NCI 5R01CA129560-03 Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas HAQUE, AZIZUL MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $296,881
Lymphoma 2011 NCI 5R21CA141324-02 Abrogating human CD59 activity for antibody-based cancer therapy QIN, XUEBIN HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $214,562
Lymphoma 2011 NCI 5R01CA066519-17 EBV-based Strategies for AIDS-related Malignancies KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $261,710
Lymphoma 2011 NCI 5R00CA126186-05 Functions of microRNAs in lymphomagenesis HE, LIN UNIVERSITY OF CALIFORNIA BERKELEY CA $239,456
Lymphoma 2011 NCI 5R01CA102184-06 Functional Analysis of p53 Polymorphic Variants MURPHY, MAUREEN FOX CHASE CANCER CENTER PA $326,484
Lymphoma 2011 NCI 5R01CA139319-02 The ARF Tumor Suppressor MURPHY, MAUREEN FOX CHASE CANCER CENTER PA $351,225
Lymphoma 2011 NCI 5R01CA122539-04 Lymphoproliferative Disorders in Primary Immunodeficiencies ROUTES, JOHN MEDICAL COLLEGE OF WISCONSIN WI $282,926
Lymphoma 2011 NCI 5R01CA132840-03 Function of REV3L in limiting oncogenesis via DNA damage tolerance WOOD, RICHARD UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $309,964
Lymphoma 2011 NCI 5R01CA076287-13 Pretargeted Radioimmunotherapy of CD20+ Lymphomas PRESS, OLIVER FRED HUTCHINSON CANCER RESEARCH CENTER WA $353,533
Lymphoma 2011 NIAID 5R01AI018757-29 Host Immunity to EBV Infection in Vitro and in VIvo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $404,291
Lymphoma 2011 NCI 5R01CA133027-04 EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN MADISON WI $291,367
Lymphoma 2011 NCI 5R01CA070723-15 Genetic Analysis of EBV's Immortalizing Genes SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN MADISON WI $285,015
Lymphoma 2011 NCI 5R01CA142664-02 Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks. YOTNDA, PATRICIA BAYLOR COLLEGE OF MEDICINE TX $308,958
Lymphoma 2011 NCI 5R01CA093237-10 Nuclear Accumulation of Cyclin D1 and Oncogenesis DIEHL, JOHN UNIVERSITY OF PENNSYLVANIA PA $282,349
Lymphoma 2011 NCI 5R01CA143032-02 Molecular Targeting of Diffuse Large B-cell Lymphoma MELNICK, ARI WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $587,846
Lymphoma 2011 NCI 5R01CA130752-04 Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $299,900
Lymphoma 2011 NCI 5R01CA129682-03 Regulation of Autophagy and Tumorigenesis by Bif-1 WANG, HONG-GANG PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $312,178
Lymphoma 2011 NCI 5R01CA068051-16 Pathogenesis of EBV Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $454,973
Lymphoma 2011 NCI 5R01CA124332-05 Regulation of KSHV infection and replication by MAPK pathways GAO, SHOU-JIANG UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $89,923
Lymphoma 2011 NCI 5R01CA125658-05 Rac GTPases as Targets in Lymphomagenesis ZHENG, YI CHILDREN'S HOSPITAL MEDICAL CENTER CINCI OH $276,450
Lymphoma 2011 NCI 5R01CA098495-08 The Regulation of Somatic Hypermutation PAPAVASILIOU, F. ROCKEFELLER UNIVERSITY NY $266,163
Lymphoma 2011 NCI 5R01CA073507-14 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $366,175
Lymphoma 2011 NCI 5R01CA116933-05 Preventing Tumorigenesis in Developing Lymphocytes ZHU, CHENGMING UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $283,822
Lymphoma 2011 NCI 5F32CA132350-03 Coordinate Suppression of B Cell Lymphoma by PTEN and SHIP MILETIC SEDY, ANA SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $54,734
Lymphoma 2011 NCI 5R01CA117935-05 p53-Independent Pathways in Mdm2-Mediated Transformation EISCHEN, CHRISTINE VANDERBILT UNIVERSITY TN $281,892
Lymphoma 2011 NCI 5R01CA091791-10 Reactivation of Kaposi's sarcoma-associated herpesvirus SUN, REN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $273,019
Lymphoma 2011 NIGMS 1R01GM095606-01 Coiled-coil Based Drug-Free Macromolecular Therapeutics KOPECEK, JINDRICH UNIVERSITY OF UTAH UT $284,050
Lymphoma 2011 NCI 5R01CA128941-04 Regulatory T cells in B cell lymphoma LEVITSKY, HYAM JOHNS HOPKINS UNIVERSITY MD $330,091
Lymphoma 2011 NCI 5R01CA134451-03 Computer-assisted Grading and Risk Stratification of Follicular Lymphoma GURCAN, METIN OHIO STATE UNIVERSITY OH $272,401
Lymphoma 2011 NCI 1R01CA155143-01 Predictors of clinical outcome after therapeutic vaccination in follicular lympho NEELAPU, SATTVA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $494,701
Lymphoma 2011 NCI 5R01CA103642-08 Immune surveillance in murine gammaherpesvirus infection USHERWOOD, EDWARD DARTMOUTH COLLEGE NH $276,154
Lymphoma 2011 NCI 5R01CA098285-08 Towards a Mouse Model of Classical Hodgkin's Disease and PTLD RAJEWSKY, KLAUS IMMUNE DISEASE INSTITUTE, INC. MA $490,125
Lymphoma 2011 NCI 1R21CA156088-01 Targeted therapy of pancreatic cancer with in vivo radionuclide generator DADACHOVA, EKATERINA ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $180,525
Lymphoma 2011 NCI 5F32CA139883-02 The role of miR-155 in cell cycle regulation and tumorigenesis SO, ALEX CALIFORNIA INSTITUTE OF TECHNOLOGY CA $51,326
Lymphoma 2011 NCI 5R01CA099997-08 Mechanisms of Alteration of B Lymphocyte Function by LMP1 BISHOP, GAIL UNIVERSITY OF IOWA IA $323,724
Lymphoma 2011 NCI 5R01CA058853-18 Regulation of EBV Infection in Epithelial Cells KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $284,873
Lymphoma 2011 NCI 5R37CA012055-39 Studies of Epstein-Barr Virus MILLER, I. YALE UNIVERSITY CT $446,398
Lymphoma 2011 NCI 5R01CA089305-10 MYC's Role in the Initiation and Maintenance of Cancer FELSHER, DEAN STANFORD UNIVERSITY CA $387,426
Lymphoma 2011 NCI 5R01CA149707-02 Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster VENTURA, ANDREA SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $384,234
Lymphoma 2011 NCI 5R01CA071540-14 Molecular Basis of Action of the Putative Oncogene BCL-6 BARDWELL, VIVIAN UNIVERSITY OF MINNESOTA TWIN CITIES MN $301,712
Lymphoma 2011 NIAID 5R01AI023283-26 Molecular Basis of Immunoglobulin Heavy Chain Switch STAVNEZER, JANET UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $454,459
Lymphoma 2011 NCI 5R01CA104588-07 RAG-induced DNA damage: mechanisms and responses ROTH, DAVID NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $290,271
Lymphoma 2011 NCI 5R01CA133571-02 Coordinately regulated alternative splicing in DNA damage and cancer CHANDLER, DAWN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $260,853
Lymphoma 2011 NCI 5R01CA142798-02 The contribution of protein translation to tumorigenesis WENDEL, HANS-GUIDO SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $382,423
Lymphoma 2011 NCI 5R01CA138747-02 microRNA-155 and Lymphoma AGUIAR, RICARDO UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $298,894
Lymphoma 2011 NCI 5R01CA136905-03 Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma ELENITOBA-JOHNSON, KOJO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $278,653
Lymphoma 2011 NCI 5R01CA132638-04 Anti-viral IL6 approach to mitigate KSHV-related disease WONG, SCOTT OREGON HEALTH AND SCIENCE UNIVERSITY OR $600,638
Lymphoma 2011 NCI 2P50CA107399-06A1 City of Hope Lymphoma SPORE FORMAN, STEPHEN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $2,185,000
Lymphoma 2011 NCI 5R01CA131024-03 The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis KRUGER, WARREN FOX CHASE CANCER CENTER PA $351,225
Lymphoma 2011 NIBIB 5R01EB002991-08 Biofunctional Polymers for Intracellular Drug Delivery STAYTON, PATRICK UNIVERSITY OF WASHINGTON WA $507,449
Lymphoma 2011 NCI 5R01CA129132-04 Development of cambinol analogues as antilymphoma agents BEDALOV, ANTONIO FRED HUTCHINSON CANCER RESEARCH CENTER WA $354,244
Lymphoma 2011 NIAID 5R01AI041769-14 Cellular Mechanisms of PTLD in Transplant Recipients MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $408,411
Lymphoma 2011 NCI 5R01CA140754-02 Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort JOHNSON, CHRISTINE C HENRY FORD HEALTH SYSTEM MI $574,828
Lymphoma 2011 NHLBI 5R01HL088686-04 Modeling B cell Lymphoma in the Mouse RICKERT, ROBERT SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $584,460
Lymphoma 2011 NCI 5R01CA138636-02 BETR Therapy for Herpesvirus-Associated Tumors POMPER, MARTIN JOHNS HOPKINS UNIVERSITY MD $553,505
Lymphoma 2011 NCI 5R01CA137123-03 Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle TAO, JIANGUO H. LEE MOFFITT CANCER CTR & RES INST FL $268,903
Lymphoma 2011 NIAID 5R01AI076183-09 Structural and Functional Studies of gp42 and HLA Class II in EBV Entry LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $400,947
Lymphoma 2011 NIAID 5R01AI068907-04 Transcriptional Control of Th-POK, a Key Regulator of Lineage Control KAPPES, DIETMAR INSTITUTE FOR CANCER RESEARCH PA $496,340
Lymphoma 2011 NHLBI 5K08HL091517-04 Annexin 2 in Lymphoproliferative Angiogenesis RUAN, JIA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $131,490
Lymphoma 2011 NIDCR 5R01DE017336-06 Epigenetic Regulation of Epstein-Barr Virus Latency Programs LIEBERMAN, PAUL WISTAR INSTITUTE PA $311,677
Lymphoma 2011 NCI 5R01CA124311-05 Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $247,146
Lymphoma 2011 NCI 1R01CA148950-01A1 Regulation of Myc-Mediated Tumorigenesis EISCHEN, CHRISTINE VANDERBILT UNIVERSITY TN $388,417
Lymphoma 2011 NIAID 5R01AI077533-03 Regulation of Immunity and Inflammation by TIPE2 CHEN, YOUHAI UNIVERSITY OF PENNSYLVANIA PA $385,914
Lymphoma 2011 NIAID 5R37AI040227-16 Biochemistry and Regulation of V(D)J Recombination SCHLISSEL, MARK UNIVERSITY OF CALIFORNIA BERKELEY CA $414,829
Lymphoma 2011 NCI 5R01CA149668-02 Targeting apoptosis via chemical design of Bcl-2 antagonists PELLECCHIA, MAURIZIO SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $384,435
Lymphoma 2011 NCI 1R01CA156674-01 A Fourth Outcome: DNA Damage and the Differentiation of B Cells TEITELL, MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $314,884
Lymphoma 2011 NCI 5R03CA150070-02 Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention RYAN, ELIZABETH COLORADO STATE UNIVERSITY-FORT COLLINS CO $71,295
Lymphoma 2011 NCI 5R01CA149254-02 Antibody-CpG conjugates for the treatment of B cell lymphoma TIMMERMAN, JOHN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $309,964
Lymphoma 2011 NIAID 5R41AI087167-02 Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis PARSONS, CHRISTOPHER APOGEE BIOTECHNOLOGY CORPORATION PA $300,000
Lymphoma 2011 NCI 1R01CA152923-01A1 FLT-PET/CT for Therapy Monitoring of DLBCL QUON, ANDREW STANFORD UNIVERSITY CA $672,975
Lymphoma 2011 NIAID 5R01AI084905-02 Regulation of B cell development by the proto-oncogene LRF/Pokemon MAEDA, TAKAHIRO CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $9,424
Lymphoma 2011 NCI 5R01CA134051-05 T Cell Immunity in Endemic Burkitt Lymphoma MOORMANN, ANN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $450,184
Lymphoma 2011 NCI 5R01CA093853-09 The role of p63 and p73 in cancer MOLL, UTE STATE UNIVERSITY NEW YORK STONY BROOK NY $305,188
Lymphoma 2011 NCI 5R01CA138268-03 Role of the cellular microRNA, miR-155, in EBV type III latency signaling FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $299,900
Lymphoma 2011 NCI 5R01CA134241-03 Post-Translational Events Underlying the KSHV vGPCR Pathogenesis FENG, PINGHUI UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $316,002
Lymphoma 2011 NCI 5R01CA127238-05 Herpesvirus-induced telomerase dysregulation and tumor formation JAROSINSKI, KEITH CORNELL UNIVERSITY ITHACA NY $221,505
Lymphoma 2011 NCI 5K23CA124465-04 Novel Biologic Therapies for Hodgkin's Lymphoma KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY MD $140,940
Lymphoma 2011 NIDCR 5R01DE018304-05 ART Modulation of Viral Pathogenesis in Oral Epithelia DITTMER, DIRK UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $305,055
Lymphoma 2011 NCI 5T32CA009140-37 Immunobiology of normal and neoplastic lymphocytes PEAR, WARREN UNIVERSITY OF PENNSYLVANIA PA $666,473
Lymphoma 2011 NIAID 5R01AI089882-02 Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep WU, HAO WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $376,448
Lymphoma 2011 NCI 5U10CA013650-39 Eastern Cooperative Oncology Group HABERMANN, THOMAS MAYO CLINIC MN $211,859
Lymphoma 2011 NCI 5R01CA122645-04 Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients BERNSTEIN, STEVEN UNIVERSITY OF ROCHESTER NY $308,376
Lymphoma 2011 NCI 5K08CA140780-02 Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB GEWURZ, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $179,910
Lymphoma 2011 NIAID 5R03AI085545-02 A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA SHACKELFORD, JULIA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $73,260
Lymphoma 2011 NCI 5R01CA132098-03 HDAC Inhibitors and CTCL SHOWE, LOUISE WISTAR INSTITUTE PA $396,309
Lymphoma 2011 NCI 5R01CA096500-10 Role of KSHV K1 in viral pathogenesis DAMANIA, BLOSSOM UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $271,364
Lymphoma 2011 NCI 2R01CA117830-06 Regulation of KSHV Latency LIEBERMAN, PAUL WISTAR INSTITUTE PA $291,966
Lymphoma 2011 NCI 1U54CA155496-01 5936 Social Determinants in the Link between Obesity and Cancer HOVMAND, PETER WASHINGTON UNIVERSITY IN ST LOUIS $188,040
Lymphoma 2011 NCI 5R01CA125195-05 Molecular Pathways in Suppression and Development of T Lineage Lymphomas BASSING, CRAIG CHILDRENS HOSPITAL OF PHILADELPHIA PA $303,174
Lymphoma 2011 NIAID 5R01AI087634-02 The Role of miR-17~92 in Autoimmune Diseases XIAO, CHANGCHUN SCRIPPS RESEARCH INSTITUTE CA $529,821
Lymphoma 2011 NCI 5R01CA121039-05 B Cell Lymphoma Therapy CHOI, YONG OCHSNER CLINIC FOUNDATION LA $236,918
Lymphoma 2011 NHLBI 5R01HL076799-08 Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death SABRI, ABDELKARIM TEMPLE UNIVERSITY PA $375,000
Lymphoma 2011 NCI 5R01CA109232-07 Regulation of the KSHV Latent Promoter DITTMER, DIRK UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $234,401
Lymphoma 2011 NCI 5K07CA140360-02 Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma HUSSAIN, SHEHNAZ UNIVERSITY OF CALIFORNIA LOS ANGELES CA $125,208
Lymphoma 2011 NCI 5R01CA135531-04 Inflammation-regulated microRNA in B cell lymphoma RICKERT, ROBERT SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $347,704
Lymphoma 2011 NCI 5R01CA133063-04 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $402,448
Lymphoma 2011 NIAID 5R01AI081710-02 Mechanisms of KSHV post-transcriptional gene regulation CONRAD, NICHOLAS UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $313,830
Lymphoma 2011 NCI 5R01CA109335-06 Significance and Function of HGAL in Lymphoma LOSSOS, IZIDORE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $243,175
Lymphoma 2011 NIAID 5R01AI076972-05 Programming of CD8+ T Cell Tolerance by B Cell APC SCHOENBERGER, STEPHEN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $449,155
Lymphoma 2011 NCI 5R01CA134807-02 Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas SOTOMAYOR, EDUARDO H. LEE MOFFITT CANCER CTR & RES INST FL $455,617
Lymphoma 2011 NCI 5U10CA047559-21 Cancer and Leukemia Group B SHEA, THOMAS UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $119,336
Lymphoma 2011 NCI 5R37CA057138-21 MYC ONCOPROTEIN FUNCTION EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $828,348
Lymphoma 2011 NCI 5R01CA083823-10 Selective Forces Operative in FeLV Infection LEVY, LAURA TULANE UNIVERSITY OF LOUISIANA LA $231,959
Lymphoma 2011 NCI 1R01CA158073-01 The Role of ATM in Suppression of Lymphomas ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,864
Lymphoma 2011 NCI 5R21CA149978-02 Fractionated, Dual-targeted radioimmunotherapy for follicular lymphoma ELSTROM, REBECCA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $340,155
Lymphoma 2011 NCI 5R01CA131027-04 Chimeric T Cell for Therpay of Hodgkin Disease SAVOLDO, BARBARA BAYLOR COLLEGE OF MEDICINE TX $308,958
Lymphoma 2011 NIAID 5R01AI078267-03 Transcriptional Control of Hematopoiesis KEE, BARBARA UNIVERSITY OF CHICAGO IL $382,239
Lymphoma 2011 NCI 5R01CA072649-13 Somatic Mutation of IG Variable Regions SCHARFF, MATTHEW ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $394,809
Lymphoma 2011 NCI 5R01CA140245-02 Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction PALOMARES, MELANIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $600,681
Lymphoma 2011 NCI 1U01CA157581-01 Molecular Diagnosis and Prognosis in Aggressive Lymphoma RIMSZA, LISA UNIVERSITY OF ARIZONA AZ $600,000
Lymphoma 2011 NCI 1K08CA158069-01 The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene PHILIP, MARY UNIVERSITY OF WASHINGTON WA $167,400
Lymphoma 2011 NCI 5R01CA151955-02 A bifunctional nanomedicine for both specific imaging and targeting therapy of an ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE TX $309,964
Lymphoma 2011 NCI 5R01CA101700-07 1H NMR STUDIES OF NON-HODGKINS LYMPHOMA GLICKSON, JERRY UNIVERSITY OF PENNSYLVANIA PA $343,695
Lymphoma 2011 NCI 5R01CA147791-02 K-Rta as a Novel SUMO and Epigenetic Regulator IZUMIYA, YOSHIHIRO UNIVERSITY OF CALIFORNIA DAVIS CA $308,790
Lymphoma 2011 NIAID 5R01AI063058-07 Mechanism and regulation of DNA end processing in V(D)J recombination and repair SEKIGUCHI, JOANN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $345,409
Lymphoma 2011 NCI 5R21CA152858-02 PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS ARIAS-MENDOZA, FERNANDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $169,836
Lymphoma 2011 NCI 5R01CA127530-04 The role of protein kinase PKK in BAFF signaling and B-cell malignancies ZHAO, JIYONG UNIVERSITY OF ROCHESTER NY $309,964
Lymphoma 2011 NCI 5R37CA037295-28 AIDS Associated Lymphoproliferative Disorders DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $390,425
Lymphoma 2011 NIAID 5R01AI078980-03 Motor protein regulation of T cell receptor signaling POMERANTZ, JOEL JOHNS HOPKINS UNIVERSITY MD $401,841
Lymphoma 2011 NIAID 5R01AI072194-03 ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO CHAUDHURI, JAYANTA SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $464,567
Lymphoma 2011 NCI 1UH2CA158689-01 Role of Reactive Oxygen Species in B Lymphoma Fate CAREY, GREGORY UNIVERSITY OF MARYLAND BALTIMORE MD $254,808
Lymphoma 2011 NCI 5R00CA125994-05 Combining Computational and Experimentation to Interrogate NF-kappaB Signaling COVERT, MARKUS STANFORD UNIVERSITY CA $241,530
Lymphoma 2011 NCI 5R01CA139119-02 A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $260,852
Lymphoma 2011 NCRR 5R24RR023343-05 Herpesvirus latency and reactivation in macaque models of human disease ROSE, TIMOTHY SEATTLE CHILDREN'S HOSPITAL WA $603,389
Lymphoma 2011 NCI 5R01CA083937-09 Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis GELINAS, CELINE UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $183,634
Lymphoma 2011 NCI 5R03CA143947-02 Energy balance and nutrigenetic analysis of non-Hodgkin lymphoma BRACCI, PAIGE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $74,933
Lymphoma 2011 NCI 5R01CA127433-05 Signal transduction inhibitor therapy for Lymphoma WITZIG, THOMAS MAYO CLINIC MN $325,779
Lymphoma 2011 NIDCR 5R01DE018926-05 Pathogenesis of oral rhesus lymphocryptovirus infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $359,692
Lymphoma 2011 NCI 5R01CA056764-17 Activation of BCL-2 in Hematologic Malignancies BOXER, LINDA PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $281,785
Lymphoma 2011 NCI 5R01CA130867-04 Identifying genetic mechanisms in T-ALL with an inducible Sleeping Beauty system DUPUY, ADAM UNIVERSITY OF IOWA IA $301,913
Lymphoma 2011 NCI 1R01CA151748-01A1 Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma LEVY, RONALD STANFORD UNIVERSITY CA $491,503
Lymphoma 2011 NCI 1R01CA151899-01A1 Communication Skills Intervention to Promote Transition into Survivorship KISSANE, DAVID SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $623,331
Lymphoma 2011 NCI 1R01CA149445-01A1 A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma BIRMANN, BRENDA BRIGHAM AND WOMEN'S HOSPITAL MA $617,616
Lymphoma 2011 NIAID 5R03AI083062-02 3-D Oral Mucosa Model for EBV Pathogenesis STOWE, RAYMOND MICROGEN, LLC TX $76,725
Lymphoma 2011 NIBIB 2R01EB001994-12 Imaging Based Dosimetry for Individualized Internal Emitter Therapy DEWARAJA, YUNI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $481,328
Lymphoma 2011 NCI 5R01CA139083-03 The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma RUBENSTEIN, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $310,117
Lymphoma 2011 NCI 5R01CA104348-07 Transcriptional silencing by the BCL6 oncoprotein MELNICK, ARI WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $258,054
Lymphoma 2011 NCI 1R01CA151351-01A1 Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy GALARDY, PAUL MAYO CLINIC MN $327,228
Lymphoma 2011 NCI 1R01CA154653-01A1 Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin's lymphoma ZHU, YONG YALE UNIVERSITY CT $343,413
Lymphoma 2011 NIBIB 1R01EB012569-01A1 Multi-functional Nanocarrier against Canine Lymphoma LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $547,918
Lymphoma 2011 NCI 5R01CA047006-24 Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $554,148
Lymphoma 2011 NCI 5R01CA124596-04 Oncogenes and oncogenic microRNAs in chicken tumors BEEMON, KAREN JOHNS HOPKINS UNIVERSITY MD $324,656
Lymphoma 2011 NCI 1R01CA151533-01A1 Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma AMIN, HESHAM UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $327,850
Lymphoma 2011 NCI 1R01CA155226-01A1 Targeting the heat shock response for the therapy of DLBCL MELNICK, ARI WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $541,013
Lymphoma 2011 RMAP 5R03DA031086-02 A Cell-Based Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling DAVIS, RICHARD UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $38,315
Lymphoma 2011 NCI 5R01CA124540-04 Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis MCALLISTER-LUCAS, LINDA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $309,532
Lymphoma 2011 NCI 5R33CA116127-04 UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY COOPER, LAURENCE UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $459,850
Lymphoma 2011 NHLBI 5R01HL094603-02 Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients METES, DIANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $375,145
Lymphoma 2011 NCI 5R01CA142809-02 Signal Transduction Pathways in CD30-positive Lymphomas DUCKETT, COLIN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $309,234
Lymphoma 2011 NCI 5R01CA153248-02 Enhancing tumor-targeted antibody therapy with a second NK activating antibody. LEVY, RONALD STANFORD UNIVERSITY CA $259,878
Lymphoma 2011 NCI 5R01CA128803-05 Identifying determinants of chemotherapeutic response in vivo HEMANN, MICHAEL MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $273,789
Lymphoma 2011 NIAID 5K25AI079404-04 Light Weight Modeling of Epstein Barr Virus SHAPIRO, MICHAEL TUFTS UNIVERSITY BOSTON MA $124,632
Lymphoma 2011 OD 1R21CA152789-01A1 Eating for Life: Dietary Behaviors Among Long Term Cancer Survivors SMITH, KATHERINE JOHNS HOPKINS UNIVERSITY MD $218,819
Lymphoma 2011 NCI 1R21CA152564-01A1 Nanosensor device for the detection of H. Pylori and prevention of gastric cancer RIGAS, ANASTASIA NANOMEDICON, LLC NY $152,250
Lymphoma 2011 NCI 5R01CA076445-11 Studies of HHV-8 vIL-6 Function NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $349,564
Lymphoma 2011 NCI 5R01CA112211-05 SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY BREEN, MATTHEW NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $273,831
Lymphoma 2011 NCI 5F31CA150442-02 EBNA1 Functions Required in Burkitt's Lymphomas and Other Immortalized B-Cells WASHINGTON, AMBER LOUISIANA STATE UNIV HSC NEW ORLEANS LA $29,355
Lymphoma 2011 NCI 5R01CA152212-02 Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents CHENG, YI-QIANG UNIVERSITY OF WISCONSIN MILWAUKEE WI $218,127
Lymphoma 2011 NCI 1F32CA159469-01 Asymmetric Total Synthesis of Vindoline and Novel Analogues SKEPPER, COLIN SCRIPPS RESEARCH INSTITUTE CA $48,398
Lymphoma 2011 NIDCR 5R01DE019249-04 Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma ELENITOBA-JOHNSON, KOJO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $370,916
Lymphoma 2011 NCI 5R01CA153260-12 Control of Lineage Commitment in Developing Thymocytes KAPPES, DIETMAR INSTITUTE FOR CANCER RESEARCH PA $439,299
Lymphoma 2011 NCI 5R01CA092104-08 Biologic Therapy for B-cell non-Hodgkin's Lymphoma ANSELL, STEPHEN MAYO CLINIC MN $250,979
Lymphoma 2011 NCI 5K01CA138559-03 Antibody-mediated Gene Therapy for the Treatment of Cancer DANIELS, TRACY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $142,677
Lymphoma 2011 NCI 5R00CA131474-05 Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells NEILSON, JOEL BAYLOR COLLEGE OF MEDICINE TX $241,531
Lymphoma 2011 NCI 5R01CA092153-09 Molecular Epidemiology of NHL and CLL CERHAN, JAMES MAYO CLINIC MN $584,461
Lymphoma 2011 NCI 5R01CA137488-17 Two Compartment Models to Improve Brain Tumor Therapy NEUWELT, EDWARD OREGON HEALTH AND SCIENCE UNIVERSITY OR $464,573
Lymphoma 2011 NCI 5R01CA134234-04 Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma CHAO, CHUN KAISER FOUNDATION RESEARCH INSTITUTE CA $301,385
Lymphoma 2011 NCI 5R01CA122569-04 Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma ROOK, ALAIN UNIVERSITY OF PENNSYLVANIA PA $259,920
Lymphoma 2011 NHLBI 5F30HL103193-02 Adoptive cell therapy for lymphoma: A study on the role of CD4 memory T cells in GOLDSTEIN, MATTHEW STANFORD UNIVERSITY CA $31,130
Lymphoma 2011 NIA 5F30AG035484-03 Role of dre-1/FBXO11 in apoptosis CHIORAZZI, MICHAEL WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $46,800
Lymphoma 2011 NCI 1R43CA153474-01A1 Virus-Targeted Therapy for Malignancies PERRINE, SUSAN PHOENICIA BIOSCIENCES, INC. MA $288,895
Lymphoma 2011 FIC 5D43CA153707-02 Developing Research Capacity for AIDS Malignancy in Kenya REMICK, SCOT WEST VIRGINIA UNIVERSITY WV $37,500
Lymphoma 2011 NCI 5D43CA153707-02 Developing Research Capacity for AIDS Malignancy in Kenya REMICK, SCOT WEST VIRGINIA UNIVERSITY WV $499,475
Lymphoma 2011 NCI 5K08CA133521-03 Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $158,893
Lymphoma 2011 NCI 1R43CA159843-01 A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma BALHORN, RODNEY SHAL TECHNOLOGIES, INC. CA $149,959
Lymphoma 2011 NIAID 1F32AI093076-01A1 The role of Bcl6 in the differentiation and function of Tfh KROENKE, MARK LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $17,061
Lymphoma 2011 NIAAA 5R01AA017972-03 Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction GARTENHAUS, RONALD UNIVERSITY OF MARYLAND BALTIMORE MD $339,003
Lymphoma 2011 NCI 5R01CA095318-07 Role of B Cells in Murine Gammaherpesvirus-68 Latency SPECK, SAMUEL EMORY UNIVERSITY GA $330,795
Lymphoma 2011 NCI 1R13CA159723-01 1st International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymp METZGER, MONIKA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $5,000
Lymphoma 2011 NCI 5K08CA140718-03 Regulation and Dysregulation of Antibody Diversification STROUT, MATTHEW YALE UNIVERSITY CT $174,420
Lymphoma 2011 NCI 1R13CA159842-01 Beyond GWAS: the next 10 years of InterLymph COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $10,000
Lymphoma 2011 NIEHS 1R13CA159842-01 Beyond GWAS: the next 10 years of InterLymph COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $2,000
Lymphoma 2011 NCI 2R01CA090571-10 CRTC2 in Cellular Development, Function, and Neoplasia TEITELL, MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $273,031
Lymphoma 2011 NCI 5F32CA139868-03 Development of a Pd Catalyzed 3+2 Annulation and Synthesis of Daphnicyclidin B MANNING, JAMES UNIVERSITY OF CALIFORNIA IRVINE CA $53,042
Lymphoma 2011 NCI 2P01CA044991-23A1 8453 Radioimmunotherapy for Lymphoma GOPAL, AJAY FRED HUTCHINSON CANCER RESEARCH CENTER WA $275,955
Lymphoma 2011 NCI 2P01CA044991-23A1 8454 Pretargeted Radioimmunotherapy for Hematologic Malignancies PRESS, OLIVER FRED HUTCHINSON CANCER RESEARCH CENTER WA $324,833
Lymphoma 2011 NCI 2P01CA044991-23A1 8455 Administrative and Statistical Core PRESS, OLIVER FRED HUTCHINSON CANCER RESEARCH CENTER WA $455,374
Lymphoma 2011 NCI 2P01CA044991-23A1 8456 Nuclear Medicine Core RAJENDRAN, JOSEPH FRED HUTCHINSON CANCER RESEARCH CENTER WA $631,694
Lymphoma 2011 NCI 2P01CA044991-23A1 8457 Biologics Production Core BALDWIN, JANELL FRED HUTCHINSON CANCER RESEARCH CENTER WA $143,546
Lymphoma 2011 NCI 5K23CA140722-02 Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma FAN, ALICE STANFORD UNIVERSITY CA $173,448
Lymphoma 2011 NCI 5R01CA116481-05 The Role of Fbxw7 in genetic instability and cancer MAO, JIAN-HUA UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $345,303
Lymphoma 2011 NCI 5R01CA108609-08 Anti-viral DC/NK interactions MUNZ, CHRISTIAN UNIVERSITY OF ZURICH SWITZE $176,961
Lymphoma 2011 NCI 5R01CA130826-04 Software & Hardware Inference Engines for Automated Determination of Primary Cell NOLAN, GARRY STANFORD UNIVERSITY CA $1,616,284
Lymphoma 2011 NCI 5K01CA122192-05 Cooperation of PTEN and SHIP as tumor suppressors in B-Cells PEDERSEN, IRENE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $137,220
Lymphoma 2011 NIAID 5R01AI085024-03 Gene and Cytokine Expression in Tolerance and GVHD STROBER, SAMUEL STANFORD UNIVERSITY CA $392,040
Lymphoma 2011 FIC 5D43CA153715-02 Columbia-South Africa Training Program for Research on HIV-associated Malignanci NEUGUT, ALFRED COLUMBIA UNIVERSITY HEALTH SCIENCES NY $37,500
Lymphoma 2011 NCI 5D43CA153715-02 Columbia-South Africa Training Program for Research on HIV-associated Malignanci NEUGUT, ALFRED COLUMBIA UNIVERSITY HEALTH SCIENCES NY $491,712
Lymphoma 2011 NCI 5K08CA127353-04 Epigenetic Mechanisms of Lymphomagenesis. SHAKNOVICH, RITA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $138,672
Lymphoma 2011 NCI 5K24CA128953-04 Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer ANTONIA, SCOTT H. LEE MOFFITT CANCER CTR & RES INST FL $171,205
Lymphoma 2011 NCI 5K08CA143151-02 Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma VEGA-VAZQUEZ, FRANCISCO UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $170,640
Lymphoma 2011 NCI 2R01CA088763-10A1 LANA and Cellular Gene Expression RENNE, ROLF UNIVERSITY OF FLORIDA FL $230,935
Lymphoma 2011 NIDCR 1P01DE021954-01 5226 Cell Core BARCY, SERGE SEATTLE CHILDREN'S HOSPITAL WA $182,906
Lymphoma 2011 NCI 5R01CA102667-07 Effects of Malaria on EBV Persistence in Children ROCHFORD, ROSEMARY UPSTATE MEDICAL UNIVERSITY NY $284,657
Lymphoma 2011 NIAID 5R01AI078234-03 New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome MIKOVITS, JUDY WHITTEMORE PETERSON INSTITUTE NV $302,866
Lymphoma 2011 NCI 1R01CA154228-01A1 Targeting vFLIP for the treatment of KSHV-associated malignancies CESARMAN, ETHEL WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $350,675
Lymphoma 2011 NCI 5R03CA150037-02 Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors BRACCI, PAIGE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $74,933
Lymphoma 2011 NCI 5R01CA129962-04 Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma BHALLA, KAPIL UNIVERSITY OF KANSAS MEDICAL CENTER KS $301,913
Lymphoma 2011 NCI 5K99CA151827-02 ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS DOMINGUEZ-SOLA, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $144,645
Lymphoma 2011 RMAP 5R01ES020116-02 Epigenomic profiling of histone turnover kinetics in mammalian cells HENIKOFF, STEVEN FRED HUTCHINSON CANCER RESEARCH CENTER WA $481,299
Lymphoma 2011 NCI 1R01CA160556-01 Escape from gammaherpesvirus-induced mRNA destruction GLAUNSINGER, BRITT UNIVERSITY OF CALIFORNIA BERKELEY CA $305,527
Lymphoma 2011 NCI 5K08CA148821-02 The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma DAVILA, MARCO SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $168,661
Lymphoma 2011 NCI 5R43CA153811-02 Rare Protein Detection on Cell Surfaces: Ultrasensitive Detection of B-Cell Chron KOHNE, DAVID JADEN BIOSCIENCE, INC. CA $157,179
Lymphoma 2011 NCI 5R44CA141754-03 Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy ROSSI, EDMUND IMMUNOMEDICS, INC. NJ $2,283,892
Lymphoma 2011 NCI 5R01CA156690-02 TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS OLTZ, EUGENE WASHINGTON UNIVERSITY MO $316,215
Lymphoma 2011 RMAP 5R01CA156690-02 TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS OLTZ, EUGENE WASHINGTON UNIVERSITY MO $322,733
Lymphoma 2011 NCI 2P01CA087497-11 Roles and regulation of p53 PRIVES, CAROL COLUMBIA UNIV NEW YORK MORNINGSIDE NY $1,812,196
Lymphoma 2011 NCI 1R01CA160300-01 Cellular Response to Short Telomeres in B-Cell Lymphoma GREIDER, CAROL JOHNS HOPKINS UNIVERSITY MD $537,001
Lymphoma 2011 NCI 2R01CA115284-06A1 KSHV RTA: more than viral replication JUNG, JAE UNIVERSITY OF SOUTHERN CALIFORNIA CA $303,371
Lymphoma 2011 NCI 1R01CA161026-01 Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies SHIPP, MARGARET DANA-FARBER CANCER INSTITUTE MA $449,734
Lymphoma 2011 NCI 1K05CA160724-01 Survivorship: Mentoring and Bridging Primary Care and Oncology OEFFINGER, KEVIN SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $164,278
Lymphoma 2011 NCI 2P01CA019014-32A1 6231 DNA-Protein Interactions in Herpes Viruses GRIFFITH, JACK UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $270,533
Lymphoma 2011 NCI 2P01CA019014-32A1 6234 Cellular Reprogramming by KSHV Latent Genes and miRNAs DITTMER, DIRK UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $291,273
Lymphoma 2011 NCI 2P01CA019014-32A1 6235 Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2) RAAB-TRAUB, NANCY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $291,372
Lymphoma 2011 NHLBI 1U10HL109322-01 The Ohio State Blood and Marrow Transplant Reseach Consortium DEVINE, STEVEN OHIO STATE UNIVERSITY OH $176,467
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer